Trial Profile
A Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety and Efficacy of Bimatoprost Solution 0.03%, 0.1%, and 0.3% Compared with Vehicle in Women with Female Pattern Hair Loss with an Open-label Active Comparator (Minoxidil 2%) Group
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2016
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary) ; Minoxidil
- Indications Female pattern baldness
- Focus Therapeutic Use
- Sponsors Allergan
- 22 May 2014 New trial record
- 19 Sep 2012
- 01 Feb 2012